Looking Into Vertex Pharmaceuticals's Recent Short Interest
Portfolio Pulse from Benzinga Insights
Vertex Pharmaceuticals' (NYSE:VRTX) short percent of float has decreased by 4.5% since its last report, with 2.73 million shares sold short, representing 1.06% of all regular shares available for trading. This decrease in short interest could indicate a more bullish market sentiment towards the stock. Compared to its peers, Vertex has less short interest, with the average for its peer group being 3.83%.

September 06, 2023 | 3:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Decrease in short interest in Vertex Pharmaceuticals could indicate a more bullish sentiment towards the stock. The company has less short interest compared to its peers.
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. A decrease in short interest can signal that investors have become more bullish. Given that Vertex's short interest has decreased, this could indicate a more bullish sentiment towards the stock. Furthermore, compared to its peers, Vertex has less short interest, which could be seen as a positive sign by investors.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 100